Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as alanosine, use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: This phase I trial is studying the side effects and best dose of alanosine in
treating patients with high-grade progressive or recurrent malignant gliomas.